health.economictimes.indiatimes

Metropolis conducts comprehensive study to detect genuine high-risk pregnancies

The study revealed that out of 140,528 pregnancies, 5,879 were initially identified as high-risk through traditional early trimester screenings. However, by integrating NIPT with the pregascreen ...
Webindia 123

Metropolis Healthcare's Comprehensive Study Reveals Key Insights in Prenatal Testing to detect Genuine High-risk Pregnancies

New Delhi [India], May 29: In its ongoing commitment to raise awareness about women's and child health issues, Metropolis Healthcare Limited, India's leading diagnostic service provider, is dedicated ...
Yahoo Finance

Chromosomal Microarray Market Trends, Analysis, and Forecast 2025-2034 | Rising Demand for Genetic Diagnostics, Integration with Genomic Medicine Drives Innovations and ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...
Business Wire

Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
technologynetworks

Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions To Comply With IVDR Regulation

Thermo Fisher Scientific Inc., announced that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic ...